logo-loader

Kirrhos Pharmaceuticals

Receive alerts
Market:
PRIVATE
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Manufacturer of small molecule inhibitor drugs intended to treat nonalcoholic steatohepatitis. The company offers an oral medicine to treat a severe form of non-alcoholic fatty liver disease.